one area we like, you know, from a defensive standpoint is large cap pharma. you've seen this big race for record setting inflows into high yield bonds. we think one area that pays dividends that has been overlooked is large cap pharma. and we like names like johnson & johnson, merck and in particular pfizer. cheryl: those are the three names. you also like some drug distribution companies. one name? >> yeah, cardinal health. if you look at what happened over the last several years, we had a big pick-up in the generic pipeline, 2013, there's a big drop-off, but coming in 2014, 2015, is another big generic wave, particularly for the so-called limited source drugs, which are limited to a couple distributors, and that should be good for companies like cardinal health. cheryl: all right. well certainly again earnings season is picking up. i'm curious in this healthcare space particularly if we're going to get upside surprises when it comes to earnings and dividends. >> we think you will see upside surprises particularly in healthcare after the recent jpmorgan heal